Ambeed.cn

首页 / 抑制剂/激动剂 / 神经信号通路 / NK Receptor

货号 产品名 纯度
A1545169 Elinzanetant

98%
A875802 SB-222200

SB-222200 is a selective, reversible and competitive antagonist of human NK-3 receptor (Ki=4.4 nM) that effectively crosses the blood-brain barrier.

99%+
A308950 Tradipitant

Tradipitant is the 2nd generation neurokinin-1 receptor antagonist, which showed activity in preclinical anxiety models.

99%+
A725085 Fezolinetant

Fezolinetant is Neurokinin-3 (NK-3) receptor antagonist.

99%+
A801868 L-732138

L-732138 is a potent and highly selective competitive tachykinin NK1 receptor antagonist with IC50 of 2.3 nM.

99%+
A103179 Aprepitant/阿瑞匹坦

Aprepitant is a selective and high-affinity neurokinin-1 receptor antagonist with IC50 of 0.1 nM.

98%
A612810 Maropitant/马罗皮坦

Maropitant is a neurokinin (NK1) receptor antagonist.

98%
A455841 Fosaprepitant Dimeglumine/福沙匹坦二甲葡胺

Fosaprepitant Dimeglumine is a prodrug for aprepitant which is a selective and high-affinity antagonist of NK1 receptor.

98%
A1209207 SB 218795

97%
A1374205 Neurokinin A TFA

98%
A1374193 [Sar9,Met(O2)11]-Substance P TFA

99%
A1374209 Substance P(1-7) TFA

99%+
A190999 Rolapitant/罗拉匹坦

Rolapitant inhibits CYP2D6, breast cancer resistance protein (BCRP), and Neurokinin (NK)1 Receptor.

98%
A1366019 Substance P TFA

Substance P TFA (Neurokinin P TFA) is a neuropeptide, acting as a neurotransmitter and as a neuromodulator in the CNS. The endogenous receptor for substance P is neurokinin 1 receptor (NK1-receptor, NK1R)[1].

99%
A913871 Netupitant/奈妥吡坦

Netupitant a potent and highly selective NK1 receptor antagonist with Ki of 0.95 nM.

98%
A725414 [Sar9,Met(O2)11]-Substance P

98%
A725311 Vapreotide acetate/醋酸伐普肽

98%
A725436 Hemokinin 1 (mouse)

98%
A1158494 Substance P(1-7)

98%
A1176607 SCH 900978

99+%
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。